Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N,N'- diacetylbenzidine

Drug Metabolism and Disposition

Volumn 25, Issue 4, 1997, Pages 481-488

  Lakshmi, Vijaya M ^b   Zenser, Terry V ^a   Davis, Bernard B ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLORO 6 PHENYLPHENOXY)ETHYLAMINE; AJMALINE; ALPHA NAPHTHOFLAVONE; BENZIDINE DERIVATIVE; BETA NAPHTHOFLAVONE; CYTOCHROME P450; CYTOCHROME P450 INHIBITOR; DISULFIRAM; ELLIPTICINE; FURAFYLLINE; PROADIFEN; SULFINPYRAZONE; THIAMAZOLE; TROLEANDOMYCIN; YOHIMBINE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGEN DNA INTERACTION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INDUCTION; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER MICROSOME; MALE; METABOLIC INHIBITION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RADIOACTIVITY; RAT;

ANIMALS; BENZIDINES; BETA-NAPHTHOFLAVONE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; ENZYME INHIBITORS; MICROSOMES, LIVER; OXIDATION-REDUCTION; PROADIFEN; RATS;

EID: 0030912472     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. C.B. Frederick, C. C. Weis, T. J. Flammang, C. N. Martin, and F. F. Kadlubar: Hepatic N-oxidation, acetyl-transfer and DNA-binding of the acetylated metabolites of the carcinogen, benzidine. Carcinogenesis 6, 959-965 (1985).
2. R. K. Lynn, C. Garvie-Gould, D. F. Milam, K. F. Scott, C. L. Eastman, and R. M. Rodgers: Metabolism of the human carcinogen, benzidine, in the isolated perfused rat liver. Drug Metab. Dispos. 11, 109-114 (1983).
3. R. K. Lynn, C. T. Garvie-Gould, D. F. Milam, K. F. Scott, C. L. Eastman, A. M. Ilias, and R. M. Rodgers: Disposition of the aromatic amine, benzidine, in the rat: characterization of mutagenic urinary and biliary metabolites. Toxicol. Appl Pharmacol. 72, 1-14 (1984).
4. V. M. Lakshmi, D. A. Bell, M. A. Watson, T. V. Zenser, and B. B. Davis: N-Acetylbenzidine and N,N′-diacetylbenzidine formation by rat and human liver slices exposed to benzidine. Carcinogenesis 16, 1565-1571 (1995).
5. W. Bi, R. B. Hayes, P. Feng, Y. Qi, X. You, J. Zhen, M. Zhang, B. Qu, Z. Fu, M. Chen, H. T. Co Chien, and W. J. Blot: Mortality and incidence of bladder cancer in benzidine-exposed workers in China. Am. J. Ind. Med. 21, 481-489 (1992).
6. T. J. Haley: Benzidine revisited: a review of the literature and problems associated with the use of benzidine and its congeners. Clin. Toxicol. 8, 13-42 (1975).
7. J. L. Radomski: The primary aromatic amines: their biological properties and structure-activity relationships. Annu. Rev. Pharmacol. Toxicol. 19, 129-157 (1979).
8. C. N. Martin, F. A. Beland, R. W. Roth, and F. F. Kadlubar: Covalent binding of benzidine and N-acetylbenzidine to DNA at the C-8 atom of deoxyguanosine in vivo and in vitro. Cancer Res. 42, 2678-2686 (1982).
9. J. C. Kennelly, F. A. Beland, F. F. Kadlubar, and C. N. Martin: Binding of N-acetylbenzidine and N,N′-diacetylbenzidine to hepatic DNA of rat and hamster in vivo and in vitro. Carcinogenesis 5, 407-412 (1984).
10. N. Rothman, V. K. Bhatnagar, R. B. Hayes, T. V. Zenser, S. K. Kashyap, M. A. Butler, D. A. Bell, V. Lakshmi, M. Jaeger, R. Kashyap, A. Hirvonen, P. A. Schulte, M. Dosemeci, F. Hsu, D. J. Parikh, B. B. Davis, and G. Talaska: The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc. Natl. Acad. Sci. U.S.A. 93, 5084-5089 (1996).
11. K. C. Morton, C. M. King, and K. P. Baetcke: Metabolism of benzidine to N-hydroxy-N,N′-diacetylbenzidine and subsequent nucleic acid binding and mutagenicity. Cancer Res. 39, 3107-3113 (1979).
12. K. C. Morton, F. A. Beland, F. E. Evans, N. F. Fullerton, and F. F. Kadlubar: Metabolic activation of N-hydroxy-N,N′-diacetylbenzidine by hepatic sulfotransferase. Cancer Res. 40, 751-757 (1980).
13. 1 exo-epoxides and endo-epoxides by rat and human glutathione S-transferases. Chem. Res. Toxicol. 5, 470-478 (1992).
14. 1 hydroxylation by the pregnenolone-16α-carbonitrile-inducible form of rat liver microsomal cytochrome P-450. Carcinogenesis (Lond.) 9, 2103-2108 (1988).
15. A. Orzechowski, D. Schrenk, H. A. J. Schut, and K. W. Bock: Consequences of 3-methylcholanthrene-type induction for the metabolism of 4-aminobiphenyl in isolated rat hepatocytes. Carcinogenesis 15, 489-494 (1994).
16. V. M. Lakshmi, M. B. Mattammal, L. A. Spry, F.F. Kadlubar, T. V. Zenser, and B. B. Davis: Metabolism and disposition of benzidine in the dog. Carcinogenesis 11, 139-144 (1990).
17. J. G. Westra: A rapid and simple synthesis of reactive metabolites of carcinogenic aromatic amines in high yield. Carcinogenesis 2, 355-357 (1981).
18. V. M. Lakshmi, N. T. Zenser, F. F. Hsu, M. B. Mattammal, T. V. Zenser, and B. B. Davis: NADPH-dependent oxidation of benzidine by rat liver. Carcinogenesis 17, 1941-1947 (1996).
19. T. V. Zenser, M. B. Mattammal, and B. B. Davis: Differential distribution of the mixed-function oxidase activities in rabbit kidney. J. Pharmacol. Exp. Ther. 207, 719-725 (1978).
20. F. P. Guengerich, P. Wang, and N. K. Davidson: Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry 21, 1698-1706 (1982).
21. R. C. Gupta, K. Earley, and S. Sharma: Use of human peripheral blood lymphocytes to measure DNA binding capacity of chemical carcinogens. Proc. Natl. Acad. Sci. U.S.A. 85, 3513-3517 (1988).
22. 32P-Postlabeling analysis of non-radioactive aromatic carcinogen-DNA adducts. Carcinogenesis (Lond.) 3, 1081-1092 (1982).
23. 32P-postlabeling analysis of aromatic carcinogen-DNA adducts. Cancer Res. 45, 5656-5662 (1985).
24. V. M. Lakshmi, T. V. Zenser, H. D. Goldman, G. G. Spencer, R. C. Gupta, F. F. Hsu, and B. B. Davis: The role of acetylation in benzidine metabolism and DNA adduct formation in dog and rat liver. Chem. Res. Toxicol. 8, 711-720 (1995).
25. W. Tassaneeyakul, D. J. Birkett, M. E. Veronese, M. E. McManus, R. H. Tukey, L. C. Quattrochi, H. V. Gelboin, and J. O. Miners: Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. J. Pharmacol. Exp. Ther. 265, 401-407 (1993).
26. M. A. Correia: Rat and human liver cytochromes P450. In "Cytochrome P450: Structure, Mechanism, and Biochemistry" (P. R. Ortiz de Montellano, ed.), pp. 607-630. Plenum Press, New York, 1995.
27. D. Sesardic, A. Boobis, B. Murray, S. Murray, J. Segura, R. De La Torre, and D. Davies: Furafylline is a potent and selective inhibitor of cytochrome P450 1A2 in man. Br. J. Clin. Pharmacol. 29, 651-663 (1990).
28. C. B. Frederick, J. B. Mays, D. M. Ziegler, F. P. Guengerich, and F. F. Kadlubar: Cytochrome P-450-and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA. Cancer Res. 42, 2671-2677 (1982).
29. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. U.S.A. 86, 7696-7700 (1989).
30. N. Battula, H. A. J. Schut, and S. S. Thorgeirsson: Cytochrome P4501A2 constitutively expressed from transduced DNA mediates metabolic activation and DNA-adduct formation of aromatic amine carcinogens in NIH 3T3 cells. Mol. Carcinogen. 4, 407-414 (1991).
31. R. J. Turesky, N. P. Lang, M. A. Butler, C. H. Teitel, and F. F. Kadlubar: Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 12, 1839-1845 (1991).
32. K. L. Kunze and W. F. Trager: Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline. Chem. Res. Toxicol. 6, 649-656 (1993).
33. G. J. Hammons, F. P. Guengerich, C. C. Weis, F. A. Beland, and F. F. Kadlubar: Metabolic oxidation of carcinogenic arylamines by rat, dog, and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. Cancer Res. 45, 3578-3585 (1985).
34. F. F. Kadlubar, J. A. Miller, and E. C. Miller: Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Res. 37, 805-814 (1977).
35. S. R. Babu, V. M. Lakshmi, F. F. Hsu, T. V. Zenser, and B. B. Davis: Glucuronidation of N-hydroxy metabolites of N-acetylbenzidine. Carcinogenesis 16, 3069-3074 (1995).
36. S. R. Babu, V. M. Lakshmi, G. P. W. Huang, T. V. Zenser, and B. B. Davis: Glucuronide conjugates of 4-aminobiphenyl and its N-hydroxy metabolites: pH stability and synthesis by human and dog liver. Biochem. Pharmacol. 51, 1679-1687 (1996).
37. M. A. Butler, F. P. Guengerich, and F. F. Kadlubar: Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis(2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Cancer Res. 49, 25-31 (1989).
38. H. Raza, R. S. King, B. Squires, F. P. Guengerich, D. W. Miller, J. P. Freeman, N. P. Lang, and F. F. Kadlubar: Metabolism of 2-amino-α-carboline: a food-borne heterocyclic amine mutagen and carcinogen by human and rodent liver microsomes and by human cytochrome P4501A2. Drug Metab. Dispos. 24, 395-400 (1996).
39. Y. Yamazoe, D. W. Miller, C. C. Weis, K. L. Dooley, T. V. Zenser, F. A. Beland, and F. F. Kadlubar: DNA adducts formed by ring-oxidation of the carcinogen 2-naphthylamine with prostaglandin H synthase in vitro and in the dog urothelium in vivo. Carcinogenesis 6, 1379-1387 (1985).
40. D. W. Hein: Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta 948, 37-66 (1988).
41. F. A. Beland and F. F. Kadlubar: Metabolic activation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. In "Handbook of Experimental Pharmacology" (C. S. Cooper and P. L. Grover, eds.). Springer-Verlag, Berlin, 1994.
42. P. E. Thomas, L. M. Reik, D. E. Ryan, and W. Levin: Induction of two immunochemically related rat liver cytochrome P-450 isozymes, cytochromes P-450c and P-450d, by structurally diverse xenobiotics. J. Biol. Chem. 258, 4590-4598 (1983).
43. D. Sesardic, K. J. Cole, R. J. Edwards, D. S. Davies, P. E. Thomas, W. Levin, and A. R. Boobis: The inducibility and catalytic activity of cytochromes P450c (P450IA1) and P450d (P450IA2) in rat tissues. Biochem. Pharmacol. 39, 499-506 (1990).
44. M. Canivenc-Lavier, M. Bentejac, M. Miller, J. Leclerc, M. L. Siess, and M. Suschetet: Differential effects of nonhydroxylated flavonoids as inducers of cytochrome P450 1A and 2B isozymes in rat liver. Toxicol. Appl. Pharmacol. 136, 348-353 (1996).
45. F. P. Guengerich, G. A. Dannan, S. T. Wright, M. V. Martin, and L. S. Kaminsky: Purification and characterization of liver microsomal cytochromes P-450: electrophorectic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone. Biochemistry 21, 6019-6030 (1982).